GRDN · Guardian Pharmacy Services, Inc
$44.33
+1.13% last session
End-of-day data · close of 2026-09-11
Market cap
$3B
Enterprise value
$3B
Trailing P/E
42.1
Forward P/E
30.7
Dividend yield
—
Beta
—
Avg volume
0M
Employees
4K
Daily Change %
1.13%
5 Days Change
6.43%
10 Days Change
16.99%
30 Days Change
9.96%
60 Days Change
5.93%
Month to Day Change
11.63%
Year to Day Change
44.20%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — GRDN
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-07
Latest call per bank · past 12 months
Bank of America
Buy$47.00
+7.2% vs priceJefferies
Buy$44.00
+0.4% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-07 | Oppenheimer | Maintains | Outperform | $43.00 → $49.00 |
| 2026-06-17 | Truist Securities | Maintains | Buy | $43.00 → $47.00 |
| 2026-06-17 | Bank of America | Maintains | Buy | $42.00 → $47.00 |
| 2026-05-07 | Oppenheimer | Maintains | Outperform | $38.00 → $43.00 |
| 2026-04-27 | Bank of America | Initiates | Buy | $0.00 → $42.00 |
| 2026-04-13 | Truist Securities | Maintains | Buy | $38.00 → $43.00 |
| 2026-03-30 | Jefferies | Initiates | Buy | $0.00 → $44.00 |
| 2026-03-12 | Oppenheimer | Maintains | Outperform | $35.00 → $38.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 72 — overbought territory; the recent run-up may be due for a pause.
- Price vs 50-day MA: Trading 10.8% above the 50-day MA ($40.00).
- Price vs 200-day MA: Trading 22.8% above the 200-day MA ($36.09).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is positive (+0.81) — short-term momentum is improving.
- 52-week range: Price is within 5% of the 52-week high ($44.33).
GRDN Price Chart
Loading chart for GRDN…
Fundamentals
About Guardian Pharmacy Services, Inc
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$93B -9.3% YTD
THC
Tenet Healthcare Corporation
$21B 35.4% YTD
FMS
Fresenius Medical Care AG
$12B -2.5% YTD
EHC
Encompass Health Corporation
$12B 15.1% YTD
DVA
DaVita Inc.
$12B 61.1% YTD
UHS
Universal Health Services, Inc.
$10B -19.1% YTD
ENSG
The Ensign Group, Inc.
$10B -1.3% YTD
CHE
Chemed Corp
$7B 21.7% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.